HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hypopyon in a patient with presumptive diffuse unilateral subacute neuroretinitis.

AbstractPURPOSE: To report a case of diffuse unilateral subacute neuroretinitis (DUSN) that developed an acute iridocyclitis with hypopyon. METHODS: Case report. We describe a 21-year-old male with clinical diagnosis of DUSN who developed a sudden and severe acute iridocyclitis with hypopyon after one year of follow-up that resolved after treatment with systemic corticosteroids. RESULTS: Anterior chamber paracentesis was performed and cultures were negative. Cytologic studies disclosed the presence of eosinophils. CONCLUSIONS: This unusual ocular finding may be related to the death of the nematode in the course of the disease.
AuthorsC Muccioli, R Belfort Jr (Affiliation: Department of Ophthalmology, Sao Paulo Hospital, Federal University of Sao Paulo, Paulista School of Medicine, Sao Paulo, Brazil. epmoftal at eu.ansp.br)
JournalOcular immunology and inflammation (Ocul Immunol Inflamm) Vol. 8 Issue 2 Pg. 119-21 (Jun 2000) ISSN: 0927-3948 [Print] NETHERLANDS
PMID10980685 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Glucocorticoids
Topics
  • Acute Disease
  • Adult
  • Anterior Chamber (pathology)
  • Diagnosis, Differential
  • Glucocorticoids (therapeutic use)
  • Humans
  • Iridocyclitis (diagnosis, drug therapy)
  • Male
  • Optic Neuritis (diagnosis, drug therapy)
  • Retinitis (diagnosis, drug therapy)
  • Suppuration (diagnosis, drug therapy)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD